Many patients are surprised by how intense Ozempic and Wegovy nausea can become — especially after dose increases. Here’s the science behind GLP-1 nausea, delayed digestion, bloating, and why symptoms often return during escalation.
GLP-1 medications like Wegovy, Ozempic, and Mounjaro commonly cause nausea, bloating, and vomiting during early treatment. Here’s why these symptoms happen, when they become concerning, and the evidence-based strategies clinicians use to help patients stay on therapy.
Fatigue and low energy are common concerns during Mounjaro treatment. This article explains how dehydration, reduced calorie intake, electrolyte imbalance, and heart rate changes may contribute to exhaustion—and what patients can do to manage symptoms safely.
GLP-1 injection lumps are not always caused by poor technique. Learn why semaglutide and tirzepatide injections can trigger lipohypertrophy, inflammation, and skin changes even when patients rotate sites correctly.